메뉴 건너뛰기




Volumn 57, Issue SUPPL. 1, 2010, Pages 12-13

Probiotics in irritable bowel syndrome

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; PROBIOTIC AGENT;

EID: 77956540855     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000309017     Document Type: Short Survey
Times cited : (6)

References (15)
  • 1
  • 2
    • 0037662110 scopus 로고    scopus 로고
    • Inflammatory bowel disease and irritable bowel syndrome: Separate or unified?
    • Bradesi S, McRoberts JA, Anton PA, Mayer EA: Inflammatory bowel disease and irritable bowel syndrome: separate or unified? Curr Opin Gastroenterol 2003; 19: 336-342.
    • (2003) Curr Opin Gastroenterol , vol.19 , pp. 336-342
    • Bradesi, S.1    McRoberts, J.A.2    Anton, P.A.3    Mayer, E.A.4
  • 6
    • 33947324517 scopus 로고    scopus 로고
    • Immune activation in patients with irritable bowel syndrome
    • Liebregts T, Adam B, Bredack C, et al: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-9 2 0.
    • (2007) Gastroenterology , vol.132 , pp. 913-920
    • Liebregts, T.1    Adam, B.2    Bredack, C.3
  • 7
    • 84985161098 scopus 로고
    • Probiotics in man and animals
    • Fuller R: Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-378.
    • (1989) J Appl Bacteriol , vol.66 , pp. 365-378
    • Fuller, R.1
  • 9
    • 69249145574 scopus 로고    scopus 로고
    • The efficacy of probiotics in the therapy of irri table bowel syndrome: A systematic review
    • Epub ahead of print
    • Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the therapy of irri table bowel syndrome: a systematic review. Gut 2008, Epub ahead of print.
    • (2008) Gut
    • Moayyedi, P.1    Ford, A.C.2    Talley, N.J.3
  • 11
    • 0005200297 scopus 로고    scopus 로고
    • Effects of consumption of a milk fermented by a probiotic Bifidobacteri-um animalis (strain DN-173-010) on colonic transit times in healthy humans
    • Bouvier M, Méance S, Bouley C, Berta JL, Grimaud JC: Effects of consumption of a milk fermented by a probiotic Bifidobacteri-um animalis (strain DN-173-010) on colonic transit times in healthy humans. Biosci Mi-croflora 2001; 20:43-48.
    • (2001) Biosci Mi-croflora , vol.20 , pp. 43-48
    • Bouvier, M.1    Méance, S.2    Bouley, C.3    Berta, J.L.4    Grimaud, J.C.5
  • 12
    • 57649208538 scopus 로고    scopus 로고
    • Clinical trial: The effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
    • Agrawa l A, Houghton LA, Morr is J, Reil ly B, Guyonnet D, Goupil Feuillerat N, Schlum-berger A, Jakob S, Whorwell PJ: Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008; 29:104-114.
    • (2008) Aliment Pharmacol Ther , vol.29 , pp. 104-114
    • Agrawa, L.A.1    Houghton, L.A.2    Morr Is, J.3    Reil Ly, B.4    Guyonnet, D.5    Goupil Feuillerat, N.6    Schlum-Berger, A.7    Jakob, S.8    Whorwell, P.J.9
  • 13
    • 34447298145 scopus 로고    scopus 로고
    • Effect of a fermented milk containing Bifi-dobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial
    • Guyonnet D, C hass a ny O, Duc rot t e P, P ic a rd C, Mouret M, Mercier CH, Matuchansky C: Effect of a fermented milk containing Bifi-dobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475-4 86.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 475-486
    • Guyonnet, D.1    Chassany, O.2    Ducrotte, P.3    Picard, C.4    Mouret, M.5    Mercier, C.H.6    Matuchansky, C.7
  • 14
    • 60349087099 scopus 로고    scopus 로고
    • Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults: A randomized, open-label, controlled, pilot study
    • Guyonnet D, Woodcock A, Stefani B, Tre-visan C, Hall C: Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults: a randomized, open-label, controlled, pilot study. J Dig Dis 2009; 10:61-70.
    • (2009) J Dig Dis , vol.10 , pp. 61-70
    • Guyonnet, D.1    Woodcock, A.2    Stefani, B.3    Tre-Visan, C.4    Hall, C.5
  • 15
    • 73749083065 scopus 로고    scopus 로고
    • Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: A randomised, double-blind, parallel, controlled study
    • Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O: Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. Br J Nutr 2009; 102:1654-1662.
    • (2009) Br J Nutr , vol.102 , pp. 1654-1662
    • Guyonnet, D.1    Schlumberger, A.2    Mhamdi, L.3    Jakob, S.4    Chassany, O.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.